Access Bio
A trusted partner in global health
Somerset, United States · Founded 2001
- Headquarters
- Somerset, New Jersey
- Employees
- 51–200
- Founded
- 2001
- Business Model
- B2B
- Website
- accessbio.net
- Last Round
- Venture RoundMay 2011
- Rounds
- 1
About
Access Bio, Inc. (KOSDAQ: 950130) is a New Jersey-based in vitro diagnostics company dedicated to the prevention and early diagnosis of infectious diseases through the development, manufacturing, and marketing of rapid diagnostic tests (RDTs). Founded in 2001 (incorporated 2002), Access Bio developed the widely used CareStart™ product line, which includes rapid tests for malaria, G6PD deficiency, HIV, HPV, and COVID-19. The company is a trusted partner to international public health agencies, NGOs, and governments fighting malaria and other infectious diseases in developing countries, with a global reach spanning sub-Saharan Africa, Asia, and Latin America. Access Bio operates manufacturing facilities and is listed on the Korean KOSDAQ exchange. It has received investment from the Global Health Investment Fund, reflecting its mission alignment with global health impact.
Summary
Access Bio is a Biotech company based in Somerset, United States, founded in 2001. Its most recent funding was a Venture Round round in May 2011.
Tech & App Stack
3 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2011
Similar Companies

Minneapolis-based clinical stage biotechnology company focused on the development of molecularly ...
China's leading blood products manufacturer

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform